5 found
Order:
  1.  20
    Is the Use of Cholesterol in Mortality Risk Algorithms in Clinical Guidelines Valid? Ten Years Prospective Data From the Norwegian HUNT 2 Study.Halfdan Petursson, Johann A. Sigurdsson, Calle Bengtsson, Tom I. L. Nilsen & Linn Getz - 2012 - Journal of Evaluation in Clinical Practice 18 (1):159-168.
  2.  12
    Can Individuals with a Significant Risk for Cardiovascular Disease Be Adequately Identified by Combination of Several Risk Factors? Modelling Study Based on the Norwegian HUNT 2 Population.Halfdan Petursson, Linn Getz, Johann A. Sigurdsson & Irene Hetlevik - 2009 - Journal of Evaluation in Clinical Practice 15 (1):103-109.
  3. Is the Use of Cholesterol in Mortality Risk Algorithms in Clinical Guidelines Valid? Ten Years Prospective Data From the Norwegian HUNT 2 Study.Halfdan Petursson, Johann A. Sigurdsson, Calle Bengtsson, Tom I. L. Nilsen & Linn Getz - 2012 - Journal of Evaluation in Clinical Practice 18 (1):170-171.
    Direct download  
     
    Export citation  
     
    Bookmark   2 citations  
  4. Is the Use of Cholesterol in Mortality Risk Algorithms in Clinical Guidelines Valid? Ten Years Prospective Data From the Norwegian HUNT 2 Study.Halfdan Petursson, Johann A. Sigurdsson, Calle Bengtsson, Tom I. L. Nilsen & Linn Getz - 2012 - Journal of Evaluation in Clinical Practice 18 (4):927-928.
    Direct download  
     
    Export citation  
     
    Bookmark   2 citations  
  5.  9
    Marginal Public Health Gain of Screening for Colorectal Cancer: Modelling Study, Based on WHO and National Databases in the Nordic Countries.Johann A. Sigurdsson, Linn Getz, Göran Sjönell, Paula Vainiomäki & John Brodersen - 2013 - Journal of Evaluation in Clinical Practice 19 (2):400-407.